Mark Cuban built Cost Plus Drugs. Now he’s coming for how ASCs get paid

Mark Cuban disrupted pharmaceutical pricing in 2022 with Cost Plus Drugs, a public benefit corporation that charges a flat 15% markup on generics and posts its full price list publicly, bypassing pharmacy benefit managers and intermediaries entirely.  Four years later, he is running the same playbook on how providers get paid, and ASCs are at […] The post Mark Cuban built Cost Plus Drugs. Now he’s coming for how ASCs get paid appeared first on Becker's Hospital Review | Healthcar...